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Latent class analysis was performed on migraine
symptom data collected in a Dutch population
sample (N¼12,210, 59% female) in order to obtain
empirical groupings of individuals suffering
from symptoms of migraine headache. Based
on these heritable groupings (h2¼0.49, 95% CI:
0.41–0.57) individuals were classified as affected
(migrainous headache) or unaffected. Genome-
wide linkage analysis was performed using geno-
type data from 105 families with at least 2 affected
siblings. In addition to this primary phenotype,
linkage analyses were performed for the indivi-
dual migraine symptoms. Significance levels,
corrected for the analysis of multiple traits, were
determined empirically via a novel simulation
approach. Suggestive linkage for migrainous
headache was found on chromosomes 1 (LOD¼
1.63; pointwise P¼0.0031), 13 (LOD¼1.63; P¼
0.0031), and 20 (LOD¼1.85; P¼0.0018). Interest-
ingly, the chromosome 1 peak was located
close to the ATP1A2 gene, associated with
familial hemiplegic migraine type 2 (FHM2).
Individual symptom analysis produced a LOD
score of 1.97 (P¼0.0013) on chromosome 5 (photo/
phonophobia), a LOD score of 2.13 (P¼0.0009) on
chromosome 10 (moderate/severe pain intensity)
and a near significant LOD score of 3.31
(P¼0.00005) on chromosome 13 (pulsating head-
ache). These peaks were all located near regions
previously reported in migraine linkage studies.
Our results provide important replication and
support for the presence of migraine sus-
ceptibility genes within these regions, and further
support the utility of an LCA-based phenotyping
approach and analysis of individual symptoms
in migraine genetic research. Additionally, our
novel ‘‘2-step’’ analysis and simulation approach
provides a powerful means to investigate linkage
to individual trait components.
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INTRODUCTION
Migraine is a severe headache disorder that affects approxi-
mately 15% of the population. It has been known for some time
that this disorder is under substantial genetic influence.
The heritability of migraine is commonly estimated at
approximately 50%. To date, genes have only been identified
for a rare autosomal dominant subtype of migraine, called
familial hemiplegic migraine (FHM). The ATP1A2 gene on
chromosome 1q23 (FHM2) [De Fusco et al., 2003; Vanmolkot
et al., 2003], the SCN1A gene on chromosome 2q24 [Dichgans
et al., 2005], and the CACNA1A gene on 19p13 (FHM1) [Joutel
et al., 1993; Ophoff et al., 1996] have been implicated in this
autosomal dominantly inherited disorder. Evidence is accu-
mulating that the chromosome 1 and 19 loci may also be
involved in the common migraines, although more research is
required to confirm these findings [Hovatta et al., 1994; May
et al., 1995; Ophoff et al., 1997; Nyholt et al., 1998, 2005; Jones
et al., 2001; Terwindt et al., 2001; Todt et al., 2005].
Due to the lack of biological markers for migraine, diagnosis
relies entirely on symptomatology. The disorder is most
commonly diagnosed using the classification criteria proposed
by the International Headache Society (IHS) [2004]. The IHS
diagnostic criteria are based on clinical consensus, and
require patients to have a certain number and combination of
symptoms in order to qualify for a migraine diagnosis (Table I).
Consequently, a relatively severe form of migraine is required
for a positive diagnosis. A study by Lante´ri-Minet et al. [2005]
showed that, in a large French population sample, the number
of subjects qualifying for a ‘‘probable migraine’’ diagnosis (i.e.,
one feature short of a full migraine diagnosis) was almost as
large as the number of subjects fulfilling all criteria. These
subjects may not strictly meet the criteria, but are likely to
have a genetic liability in common with subjects fulfilling a
complete migraine diagnosis. This means that excluding
subjects qualifying for a ‘‘probable migraine’’ diagnosis but
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who do not strictly fulfill the IHS migraine diagnosis will
lead to a considerable loss of power in genetic studies of
migraine.
A method that addresses this issue was proposed by Nyholt
et al. [2004]. In this study, latent class analysis (LCA) was
applied to the IHS migraine symptom data. Although empiri-
cally derived, the resulting groupings of headache sufferers
showed similar heritability to strict IHS diagnoses and remain
clinically relevant due to being derived from the IHS diagnostic
criteria. The LCA method provides a stable and quantitative
approach to diagnosing migrainous headache, resulting in
more individuals being definitively classified, thereby increas-
ing the potential power of genetic studies aimed at identi-
fying genes contributing to the underlying susceptibility of
migraine. Good correspondence between LCA-based migraine
groupings and genetic risk has been demonstrated [Nyholt
et al., 2004; Ligthart et al., 2006]. LCA has now been applied
successfully in several migraine studies [Nyholt et al., 2004,
2005; Lea et al., 2005; Ligthart et al., 2006]. In addition, the
utility of LCA-based diagnoses and analysis of individual
symptoms in genetic studies was recently highlighted in two
recent reviews on migraine genetics [van den Maagdenberg
et al., 2007; Wessman et al., 2007]. An LCA-based genetic
study of migraine in the Dutch population [Ligthart et al.,
2006] showed results very similar to those observed in the
Australian LCA study by Nyholt et al. [2004], with subgroups
of affected individuals differing in the severity rather than the
quality of their headaches. In the present study, an LCA-based
phenotype (migrainous headache) is utilized in a genetic
linkage analysis of migraine in a Dutch population sample.
METHODS
Sample
Migraine symptom data were collected in a cohort of Dutch
twins and their parents, siblings and partners. The partic-
ipants were volunteer members of the Netherlands Twin
Registry, kept by the department of Biological Psychology at
the Vrije Universiteit in Amsterdam. The data were collected
in two surveys on health, lifestyle and personality, conducted
in 2002 and 2004. Data collection procedures for both surveys
have been described in detail elsewhere [Boomsma et al., 2006;
Distel et al., 2007]. The 2002 questionnaire data were available
for 10,299 individuals (42% males, 58% females) with a mean
age of 40.0 (SD¼ 14.4, range 14–88). The 2004 questionnaire
was completed by 8645 individuals (39% males, 61% females)
with a mean age of 42.7 (SD¼ 14.6, range 15–90). Of all
participants, 6,631 individuals completed both surveys, result-
ing in a total number of 12,313 participants across the two
surveys. Migraine data were available for 12,210 individuals
(5,016 males and 7,194 females) from 4,014 families. Of these
individuals, 5,540 (45%) were twins, 1,767 (14%) were single-
ton siblings of the twins, 3,261 (27%) were parents of twins, and
1,642 (13%) were spouses of twins.
The two surveys both included the same set of headache
questions. Participants screening positive for the screening
question (do you ever experience headache attacks, for
instance migraine?) subsequently answered a set of more
detailed headache questions. This information was used to
determine the participants’ status with regard to eight of the
symptoms listed in the IHS diagnostic criteria for migraine
(Table II).
All available data were used to determine whether or not
each of the symptoms was present in an individual. Between
the two questionnaires the tetrachoric test–retest correlation
was 0.87 for the screening question, and ranged between 0.79
and 0.91 for the IHS migraine symptoms (assuming individ-
uals screening negative did not have the symptom). Given
changes in the presenting symptoms of migraine attacks
are common [Ophoff et al., 1994; Kallela et al., 2001], it was
assumed that if a participant reports a migraine symptom in
one survey but not the other, the presence of that symptom
reflects a liability to migraine and is therefore relevant to a
study of migraine genetics, even if it was not present a
few years earlier or later (i.e., ‘‘lifetime’’ migraine). Therefore,
a participant positive for a symptom in either of the two
questionnaires was treated as affected with respect to that
particular symptom.
Latent Class Analysis
LCA was used to empirically investigate the presence and
characteristics of subgroups of headache sufferers in our
sample, as previously described in detail [Nyholt et al., 2004;
Ligthart et al., 2006]. LCA investigates the relationship
between a set of observed variables (in this case migraine
symptom data) and an underlying latent (unobserved) con-
struct. The categories of this latent trait are referred to as
‘‘clusters’’ or ‘‘classes.’’ Based on the pattern of symptoms
reported, the most likely class membership is estimated for
each subject [Lazarsfeld and Henry, 1968; McCutcheon, 1987].
In this study, LCA was performed on the individual IHS
migraine symptoms, using the software package Latent
GOLD 4 (Statistical Innovations Inc., Belmont, MA). Sex was
included as a covariate, to allow for differential symptom
prevalence in males and females. Model fit was compared using
the Bayes Information Criterion (BIC), with a lower BIC
indicating a better fit to the data. The empirical groupings
resulting from this analysis were used to classify participants
as affected or unaffected for ‘‘migrainous headache.’’ This
TABLE I. Diagnostic Criteria for Migraine Without Aura, as Published by the International Headache Society [Headache
Classification Committee of the International Headache Society, 2004]
Migraine without aura
A At least five attacks fulfilling criteria B–D
B Headache attacks lasting 4–72 hr (untreated or unsuccessfully treated)
C Headache has at least two of the following characteristics:
1. Unilateral location
2. Pulsating quality
3. Moderate or severe pain intensity
4. Aggravation by or causing avoidance of routine physical activity (e.g., walking or climbing stairs)
D During headache at least one of the following:
1. Nausea and/or vomiting
2. Photophobia and phonophobia
E Not attributed to another disorder
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classification was used as the primary phenotype in the linkage
analyses. The individual migraine symptoms (independent of
affection status for migrainous headache) were used as
phenotypes in supplementary linkage analyses of implicated
regions. Analyzing a broad phenotype at the level of individual
symptoms may provide more insight into the relationships
between loci and individual symptoms [Nyholt et al., 2005].
More specifically, by analyzing symptoms independent of the
endpoint diagnosis, within-family phenotypic homogeneity is
typically increased. For example, although not all subjects
may be classified as affected for the end diagnosis they may
nonetheless all suffer a particular symptom.
For comparison purposes only, results for migraine dia-
gnosed according to strict IHS criteria (see Table I) are also
reported. The heritability and 95% confidence intervals for
migrainous headache based on LCA and IHS criteria were
estimated with Mx [Neale et al., 2003], using all available twin
data.
Genotype Data
DNA was extracted from either whole blood or buccal swabs
using standard protocols [Miller et al., 1988; Meulenbelt et al.,
1995]. Samples were genotyped by the Mammalian Geno-
typing Service in Marshfield and the Molecular Epidemiology
Section, Leiden University Medical Centre. The genotype data
from these genome-wide and some candidate region screens
were combined to a single data set where alleles of the
same markers between sets were aligned. Pedigree relation-
ships were examined using GRR (Graphic Representation of
Relationships) and errors of Mendelian inheritance were
detected with Pedstats [Abecasis et al., 2001, 2002]. Markers
and samples were removed if their total error rate was more
than 1%; in all other cases the specific erroneous genotypes
were coded as unknown. Merlin was used to detect unlikely
recombinants and erroneous genotypes were removed with
Pedwipe [Abecasis et al., 2002].
The siblings from the families informative for linkage had an
average of 345 markers typed. The average marker spacing per
individual had a median of 10 cM, and the average hetero-
zygosity of the autosomal markers was 75%. Sex-averaged,
female- and male-specific map positions were interpolated
via locally weighted linear regression from NCBI build 35.1
physical map positions and the Rutgers genetic map [Duffy,
2006] (http://www2.qimr.edu.au/davidd/master_map.dat).
Linkage Analysis
Multipoint ‘‘non-parametric’’ linkage analysis was per-
formed using Merlin [Abecasis et al., 2002]. The NPLpairs
statistic [Weeks and Lange, 1988] was used to test for increased
allele sharing among affected individuals. The genotyped
sample consisted of 3,944 individuals from 841 nuclear
families. For 2,536 of these migraine data were available.
Informative for linkage were all genotyped families in which at
least two siblings were affected. Under the LCA-based
definition of migrainous headache, 105 nuclear families were
informative, encompassing 234 affected, and 73 unaffected
siblings. Allowing for non-independence among sib pairs
derived from the same sibship (i.e., sibship of size S as being
equivalent to S-1 independent sib pairs [Suarez and Hodge,
1979]), these 105 families contained 202 independent sib pairs,
129 of which were affected concordant (of the remaining sibling
pairs in the larger families, 25 were unaffected concordant and
48 were discordant). These numbers vary for the individual
symptoms, which have different prevalences (113 informative
families for 5 attacks, 60 for 4–72 hr duration, 49 for
pulsation, 108 for moderate/severe, 74 for aggravation, 40 for
nausea/vomiting, 69 for photo-/phonophobia, and 16 for visual
aura).
LOD scores were calculated according to the Kong and Cox
exponential model [Kong and Cox, 1997]. Regions in which
LOD scores exceeded the threshold for suggestive linkage were
further explored, using the individual migraine symptoms (i.e.,
the presence of a symptom, regardless of LCA diagnosis) as
phenotypes. Finally, to ensure that no important findings
were missed due to our focus on suggestive regions only, a
genome-wide exploratory analysis was carried out for all the
phenotypes.
Empirical estimates of genome-wide significance were
obtained via gene-drop simulations performed using Merlin.
Based on the observed phenotype and genotype data, 1,000
‘‘null’’ genome scans were generated under the assumption of
no linkage. The simulated genome scans were analyzed in the
same way as the original data. From each analysis the highest
LOD score per chromosome was collected. The empirical
TABLE II. Headache Questions Included in the Surveys and Correspondence to IHS Diagnostic Criteria for Migraine
Question in survey
Code in diagnostic
criteria Description
Do you ever experience headache attacks, for instance migraine? (yes/no) Screening question
How often do you have these headache attacks?a A 5 episodes
Less than once a year
About once a year
Several times a year
About once a month
Several times a month
About once a week
Several times a week
How long do these headache attacks usually last? B 4–72 hr
The headache is usually pounding or stabbing (yes/no) C2 Pulsating quality
How intense is the headache during most attacks? (mild/moderate/severe) C3 Moderate or severe pain intensity
During a headache attack, do you experience: (yes/no)
Aggravation of headache by physical activity? C4 Aggravation by physical activity
Nausea or vomiting? D1 Nausea and/or vomiting
Aversion of light, sound or smell?b D2 Photo and phonophobia
Partial loss of vision, seeing flashes of light or (zigzag) patterns? Aura
aAn attack frequency of at least ‘‘several times a year’’ was assumed to be equivalent to ‘‘5 episodes.’’
bThe official criteria do not include osmophobia and require both photo- and phonophobia, however, from these data it was not possible to determine whether
both were present.
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significance of a LOD score was determined by counting the
proportion of genome scans containing LOD scores that
exceeded that value. Following the recommendations of
Lander and Kruglyak [1995], the threshold for suggestive
linkage was defined as the LOD score that occurred by chance
only once per genome scan, in other words, the 1,000th highest
LOD score in a total of 1,000 simulated genome scans
(LOD 1.54 in the current data). Significant linkage was
defined as a LOD score that occurs with probability 0.05 in a
genome scan, or once per 20 genome scans. This is equivalent to
the 50th highest LOD score occurring in 1,000 simulated scans
(LOD 2.82 in the current data).
The empirical significance values for the follow-up analyses
of the suggestive regions, which included the individual
symptoms as phenotypes, had to be corrected for multiple
testing. This can be done by analyzing the simulated genome
scans for all nine phenotypes, and collecting for each position
the highest LOD score across these phenotypes. Out of these
‘‘maximized’’ LOD scores, the highest LOD per chromosome
was recorded. This was done for each of the 1,000 replicates. As
in the procedure described above, the suggestive (LOD 2.4)
and significant (LOD 3.85) linkage threshold was taken as
the 1,000th and 50th highest ‘‘maximized’’ LOD scores,
respectively. This procedure was used to determine empirical
significance levels for the exploratory genome-wide linkage
analyses of LCA migrainous headache and the individual
symptoms.
However, given our primary strategy was to only follow up
the regions that showed suggestive linkage with migrainous
headache, correcting for analyzing nine phenotypes genome-
wide would lead to a conservative significant linkage thresh-
old. Therefore, we developed a novel ‘‘2-step’’ simulation
approach which examined the ‘‘maximized’’ LOD score, given
analysis of nine phenotypes, only in regions showing sug-
gestive linkage with migrainous headache. More specifically,
for each simulated genome-wide linkage scan the ‘‘maximized’’
LOD score across all phenotypes was calculated only for the
simulated chromosomes in which the simulated LOD score for
migrainous headache exceeded our initial suggestive linkage
threshold (LOD 1.54). Analysis of the resulting ‘‘maximized’’
LOD scores enables determination of a significant linkage
threshold corrected for our restricted testing of multiple
phenotypes. This significance level (LOD 3.57) will
be referred to as ‘‘2-step’’ significant linkage.
RESULTS
LCA was performed using migraine symptom data from
12,210 individuals (41% male, 59% female). Sex was included
in the models as a covariate. A five-class LCA model provided
the best fit to the data, with the minimum BIC value of
52067.28 (four- and six-class models produced larger BIC
values of 52173.47 and 52117.74, respectively). Figure 1 shows
the resulting profile plot, depicting the endorsement proba-
bility for each symptom given class membership. The subjects
screening negative (67%, N¼ 8,138, 48% male, 52% female;
data not shown) did not answer any further questions about
headache and were assumed to be unaffected for all migraine-
related symptoms. Therefore the endorsement probabilities for
this group were zero. The two least severe symptomatic
categories (5%, N¼ 647, 48% male, 52% female) can be
described as ‘‘mild non-migrainous headache.’’ These two
categories are referred to as class 1a and 1b because they are
relatively similar in both quality and severity. Typically,
individuals in these classes were unaffected (i.e., had low
endorsement probabilities) for the majority of IHS migraine
symptoms. The individuals in class 2 (12%, N¼ 1,481, 36%
male, 64% female) had a moderately severe type of migrainous
headache, typically characterized by the presence of four or
more IHS migraine symptoms, but often lacking nausea and/or
vomiting, photo- and phonophobia, and/or aura symptoms. The
individuals in the most severely affected subgroup (class 3;
16%, N¼ 1,944, 13% males, 87% females) can be described as
having ‘‘severe migrainous headaches,’’ typically including the
majority of IHS migraine symptoms.
In the genetic analyses, subjects in classes 2 and 3, who, on
average, had endorsement probabilities higher than 0.5 for the
majority of symptoms (28.1% of the sample), were treated as
‘‘affected’’ for migrainous headache. Subjects in classes 0 and
1 were considered ‘‘unaffected.’’ This classification, which is the
Fig. 1. Profile plot for the 5-class LCA model. The endorsement probabilities (y-axis) indicate the proportion of individuals within a class reporting each
symptom. In class 0 (not shown), all endorsement probabilities were zero.
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primary phenotype in our analyses, will be referred to as ‘‘LCA
migrainous headache’’ throughout the paper. To enable
a comparison with a more strict definition of migrainous
headache, we also report linkage results for an LCA-based
classification in which only class 3 individuals are treated as
affected (‘‘LCA-severe,’’ 16% of the sample) and for a classi-
fication based on strict IHS criteria (‘‘IHS migraine,’’ 12.2% of
the sample). Table III shows the number of individuals with
IHS migraine by class membership.
Maximum likelihood estimates of heritability were obtained
in Mx, using all available twin data (N¼ 2,036 pairs, 1,127 MZ,
532 DZ same sex, 377 DZ opposite sex). No significant sex
differences in genetic architecture were observed. The herita-
bility of LCA migrainous headache (49%; 95% CI: 41–57) was
slightly higher and more precise than the heritability of IHS
migraine (46%; 95% CI: 36–56) and LCA-severe (43%; 95% CI:
33–52). This indicates that the LCA migrainous headache
phenotype provides at least a similar amount of genetic
information compared to the stricter IHS and LCA-severe
diagnoses, while also increasing the number of individuals
classified as affected for migrainous headache.
LCA migrainous headache was subsequently utilized as
the primary phenotype in genome-wide linkage analysis.
Figure 2a shows the LOD scores from Merlin NPLpairs analysis
of LCA migrainous headache. For comparison, linkage results
using the LCA-severe and IHS migraine classifications are
shown in Figure 2b.
The linkage analysis of LCA migrainous headache revealed
three LOD scores that exceeded the threshold for suggestive
linkage (LOD 1.54). The highest peak was found on chromo-
some 20, at 41 cM (LOD¼ 1.85). On chromosome 1, a LOD score
of 1.63 was found at 171 cM, and a LOD score of 1.63 was found
at 91 cM on chromosome 13. These suggestive linkage regions
were subsequently investigated in a multiple phenotype
analysis of the individual migraine symptoms (Fig. 3).
Figure 3 also presents results from exploratory linkage
analysis of individual symptoms for chromosomes 5 and 10—
previously linked to LCA-derived migrainous headache in an
Australian sample [Nyholt et al., 2005]. On chromosomes 1 and
20, analyzing the individual symptoms did not result in higher
LOD scores compared to analyzing migrainous headache
only. In contrast, analysis of chromosome 13 produced a
considerably higher LOD score for ‘‘pulsating headache.’’ The
peak (LOD¼ 1.63) that reached the suggestive linkage thresh-
old for migrainous headache increased to a LOD score of 3.31 in
the analysis of pulsating headache—just falling short of our
‘‘2-step’’ significant linkage threshold of 3.57. A neighboring
peak for the same symptom, located 20 cM away, reached a
LOD score of 3.34 in the individual symptom analysis.
Finally, to exclude the possibility that linkage to individual
migraine symptoms was missed by only examining regions
reaching suggestive linkage to migrainous headache, a
genome-wide analysis was performed for migrainous headache
and all individual symptoms. Figure 4 shows the ‘‘maximized’’
LOD scores across all phenotypes for each position in the
genome. No new peaks were identified that exceeded the
empirically determined threshold for suggestive (LOD 2.4)
or significant linkage (LOD 3.85), after correcting for
exploratory analysis of multiple phenotypes genome-wide.
DISCUSSION
Linkage analysis of our primary phenotype, LCA migrainous
headache, resulted in three peaks that exceeded our threshold
for suggestive linkage, whereas only one such peak was
expected to occur by chance. To enable comparison with
previously reported linkage results for migraine, an overview
of previous studies is given in Table IV. One suggestive peak,
with a LOD score of 1.63 (pointwise P¼ 0.0031) at marker
D1S1653, was found on chromosome 1, only 5 cM from the
ATP1A2 gene, which has been demonstrated to play an
important role in FHM2. This finding is especially interesting
since in an Australian study, Nyholt et al. [2005] found a LOD
score of 1.53 in the same region. This is further evidence in
support of the hypothesis that the FHM2 gene ATP1A2 or a
flanking gene may be involved in common migraine. The fact
that numerous families contributed towards this linkage peak
indicates it is unlikely that the signal was caused by potential
FHM families, considering the low prevalence of this disorder.
Another suggestive peak was located on chromosome 13. This
peak increased substantially in the individual symptom
analysis, with pulsating headache producing the highest
LOD score of 3.31 (pointwise P¼ 0.00005). Although the
chromosome 13 peak is broad, covering a wide area of the
chromosome, it is interesting to note that the highest LOD
score found in the individual symptoms analysis is located
only 6 cM away from the locus where Nyholt et al. [2005]
found suggestive linkage for LCA migraine and the individual
photophobia symptom. That said, the broadness of the chromo-
some 13 peak may indicate the presence of multiple migraine
susceptibility loci; however, further research is required to
either confirm or exclude this possibility.
Although our final analysis, which included all phenotypes
genome-wide, did not reveal any undiscovered peaks exceeding
the threshold for suggestive linkage, a few results are worth
mentioning. A potentially interesting finding is the linkage for
moderate/severe pain intensity on chromosome 10 (highest
LOD¼ 2.13, nominal pointwise P¼ 0.0009), approximately
30 cM away from the linkage peak (marker D10S2327), but
overlapping the 95% CI, in the region reported in Australian
(highly suggestive linkage for LCA migraine) and Finnish
(nearly suggestive linkage for phonophobia) genome scans
[Nyholt et al., 2005; Anttila et al., 2006]. In addition, on
chromosome 5, a LOD score of 1.97 (pointwise P¼ 0.001) was
found for photo-/phonophobia, at marker D5S2501. This
replicates the significant linkage found by Nyholt et al.
[2005] for LCA migraine, at the same marker. It should be
emphasized that, in the absence of identified predisposing
genes for common migraine, linkage findings are our main
source of information, and replication of these findings is
crucial to be able to distinguish between true loci and false
positive findings.
The phenotype was based on a questionnaire that included
information on 8 of the symptoms listed in the IHS diagnostic
criteria for migraine. Since the questionnaire did not include
a question about unilateral location of headaches (one of
the four C-criteria in the IHS guidelines, see Table I), a
complete IHS-based diagnosis was not possible. To avoid false
positive migraine diagnoses due to missing symptom data, a
slightly more strict definition was used, in which patients were
required to have at least two of the three available C-criteria.
This may have led to a slightly conservative estimate of IHS
migraine prevalence. The possibility cannot be excluded that
the absence of information on unilateral location may have also
affected the LCA results. However, in a study of similar design
TABLE III. Number of Affected and Unaffected Individuals
Based on LCA Classification and IHS Criteria
LCA diagnosis
IHS diagnosis
Unaffected Affected
Class 0 (unaffected) 8138 (66.6%) 0 (0.0%)
Class 1 (unaffected) 644 (5.3%) 3 (0.0%)
Class 2 (affected) 1191 (9.8%) 290 (2.4%)
Class 3 (affected) 743 (6.1%) 1201 (9.8%)
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[Nyholt et al., 2004], unilateral headache was found to be one of
the features least distinctive of migraine (as opposed to non-
migrainous headache). Therefore it is not expected that
the presence of information on unilaterality would have
significantly changed the resulting classification.
The primary linkage analyses were performed using
a relatively broad definition of migrainous headache. To
examine the effects of including individuals with milder forms
of migrainous headache, we performed additional linkage
analyses on two more strictly defined phenotypes, LCA-severe
Fig. 2. Chromosome 1-22, LOD scores and empirical significance levels for linkage analysis of (a) the primary phenotype, LCA migrainous headache and
(b) IHS migraine and LCA-severe. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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and IHS migraine (Fig. 2b). Under the stricter classifications,
the number of informative families was dramatically reduced
(to 48 for LCA-severe and to 32 for IHS migraine). This is due to
the fact that even if only one sibling is unaffected under the
new classification, both members of the pair are no longer
informative for linkage. Figure 2 shows that although the
location of the main peaks do not change substantially, the
linkage peaks for the stricter definitions are generally
lower. Under the IHS definition, the chromosome 13 peak
has disappeared entirely, whereas under the LCA-severe
definition, the chromosome 13 peak is present but the peak
on chromosome 20 is much smaller. Such reductions in LOD
scores are expected with a reduction in sample size (i.e.,
reduced power).
Additional linkage analysis of chromosome 13, for (a) families
informative for IHS migraine and (b) families informative for
LCA migrainous headache but not IHS migraine, showed
that the latter families are indeed responsible for the chromo-
some 13 peak (results not shown). In other words, the observed
linkage to chromosome 13 is predominantly due to increased
allele sharing (IBD) amongst individuals suffering moderate
migrainous headaches that do not quite satisfy IHS diagnostic
Fig. 3. LOD scores for LCA migrainous headache and individual migraine symptoms; chromosomes 1, 5, 10, 13, and 20. The 2-step significance level is
indicated for the regions showing suggestive linkage in the primary analysis.
1192 Ligthart et al.
criteria. Closer inspection showed that the general frequency of
the symptoms was lower in these families, but the overall
pattern of symptoms was very similar to that in the families
informative for IHS migraine.
The agreement (Cohen’s kappa) between LCA migrainous
headache and IHS migraine was 0.53. This kappa is quite good
in light of the ambiguity associated with the clinical diagnosis
of migraine. For example, kappas range from 0.55 to
0.81 among neurologists assigning headache diagnoses based
on videotaped patient interviews [Granella et al., 1994].
Disagreement comes mainly from individuals who are unaf-
fected under the IHS classification but affected under the LCA
classification (Table III). This is not limited to the less severely
affected class 2 individuals; a substantial number of class 3
individuals were also classified as unaffected under the IHS
definition.
The comparison between LCA migrainous headache (classes
2 and 3), and LCA-severe (class 3 only) further supports the
idea that gene-finding studies may benefit from the inclusion of
individuals with mild migrainous headaches. The linkage
results for the two phenotypes are globally similar, but peaks
present in the results for LCA-severe tend to increase when
class 2 individuals are also included. Inspection of the sibling
pairs excluded from the analysis of LCA-severe showed that in
most cases one sibling was in class 2 and the other in class 3.
Although in such cases the class 2 sibling will have a milder
form of headache, the two siblings are likely to have a genetic
risk in common, which means that including class 2 siblings
adds valuable genetic information.
Our results indicate that the loss of power resulting from
exclusion of subjects with milder forms of migrainous headache
is unnecessary. Eventually, in genetic studies we are inter-
ested in genes underlying a disorder that covers a broad
spectrum of severity, and not only in cases exceeding a
particular clinical threshold. Although the LCA approach
might not necessarily be the most appropriate strategy in
clinical practice, our results support the idea that in genetic
studies it may be more effective than conventional pheno-
typing based on strict IHS diagnostic criteria.
Finally, we emphasize the advantage of our novel ‘‘2-step’’
analysis and simulation approach, which only examines
individual symptoms in regions surpassing suggestive linkage,
compared to an approach analyzing all phenotypes genome-
wide. That is, the ‘‘2-step’’ approach ensures those regions
initially reaching suggestive linkage remain so, because here
we are simply investigating the chance of obtaining significant
linkage, after examining the individual symptoms in the
suggestive regions; whereas analysis of all phenotypes
genome-wide, carries with it a higher multiple test burden.
Indeed, sole use of the latter exploratory approach would result
in only the chromosome 13 locus reaching suggestive linkage.
Given our goal of analyzing individual symptoms is to increase
the evidence for linkage at particular loci, the ‘‘2-step’’
approach makes conceptual sense since it is unlikely a non-
suggestive linkage peak obtained for an end diagnosis would
reach significant linkage for an individual symptom.
In summary, two of our suggestive peaks were located close
to loci previously reported in migraine research. To our
knowledge, the suggestive peak on chromosome 20 has not
been reported before. This study also replicated the significant
peak on chromosome 5q21 [Nyholt et al., 2005] and the highly
suggestive peak on 10q22 [Nyholt et al., 2005; Anttila et al.,
2006]. These results provide important replication and support
for the presence of migraine susceptibility genes within these
regions, and will be useful in guiding future research efforts in
the area of gene-finding. This aspect will become even more
important with the recent development towards genome-
wide association studies. Linkage results, especially when
replicated, can serve as important guidelines for the inter-
pretation of the enormous amounts of data generated by such
large-scale genotypic analyses.
Furthermore, the remarkable similarities of LCA classifica-
tion results and subsequent linkage findings in the genetically
similar Dutch and Australian populations [Sullivan et al.,
Fig. 4. Chromosome 1-22, genome-wide ‘‘maximized’’ LOD scores across all nine phenotypes (LCA migrainous headache and individual migraine
symptoms).
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2006], indicate that our LCA-based approach provides a stable
and robust migraine phenotype and should further encourage
the use of this strategy in future migraine genetic research.
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